Le Lézard
Classified in: Health, Business
Subjects: SVY, JVN

Diabetes Increases the Number of Eye Disease Patients at Risk for Blindness


CHICAGO, Oct. 28, 2019 /PRNewswire-PRWeb/ -- According to the new "World Report on Vision" from the World Health Organization, the number of people with diabetes-related retinopathy globally is estimated to increase from 146 million in 2014 to 180.6 million in 2030. And, according to the Centers for Disease Control and Prevention, diabetes is the leading cause of new cases of blindness in adults in the United States.

Prevent Blindness, the nation's oldest volunteer eye health non-profit organization, has declared November as Diabetes-related Eye Disease Awareness Month to educate the public on the effects of diabetes on vision, risk factors, and treatment options.

Prevent Blindness recently launched a new, no-cost resource, the "Diabetes and the Eyes" educational toolkit. The resource includes downloadable fact sheets, shareable infographics for social media, and financial assistance resources to increase access to eye care. For healthcare professionals, community organizers, and more, an educator course is also available, including a PowerPoint presentation and script. These materials were made possible by funding from the Allergan Foundation.

Diabetes-related eye disease refers to a group of eye problems that people with diabetes may face as a complication of the disease including diabetes-related retinopathy and diabetes-related macular edema (DME). Those with diabetes are also at greater risk for cataract and glaucoma.

People with diabetes may lower their risk of developing eye disease by:

For the second consecutive year, Oxurion NV, a biopharmaceutical company developing innovative treatments to preserve vision in patients with diabetes-related eye disease, is partnering with Prevent Blindness to raise awareness and provide education to the public as part of for November's Diabetes-related Eye Disease month.

"The longer someone has diabetes, the higher the risk for diabetes-related eye disease," said Jeff Todd, president and CEO of Prevent Blindness. "It is imperative that people with diabetes work closely with their eye doctor to take the necessary steps to help prevent significant vision loss."

For more information on diabetes-related eye disease, please visit http://www.preventblindness.org/diabetes-resources, or call Prevent Blindness at (800) 331-2020 or visit preventblindness.org.

For a free listing of organizations and services that provide financial assistance for vision care in English or Spanish, please visit https://www.preventblindness.org/vision-care-financial-assistance-information.

About Prevent Blindness

Founded in 1908, Prevent Blindness is the nation's leading volunteer eye health and safety organization dedicated to fighting blindness and saving sight. Focused on promoting a continuum of vision care, Prevent Blindness touches the lives of millions of people each year through public and professional education, advocacy, certified vision screening and training, community and patient service programs and research. These services are made possible through the generous support of the American public.

Together with a network of affiliates, Prevent Blindness is committed to eliminating preventable blindness in America. For more information, or to make a contribution to the sight-saving fund, call (800) 331-2020. Or, visit us on the Web at preventblindness.org or facebook.com/preventblindness.

 

SOURCE Prevent Blindness


These press releases may also interest you

at 04:00
Today Benchling announced that Zealand Pharma A/S, ("Zealand") a biotechnology company focused on the discovery and development of peptide-based medicines, has selected the Benchling R&D Cloud as its central source of truth for scientific data,...

at 03:38
Medivir AB (STO: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today an update from a Type C meeting with the FDA, regarding the company's plans for a global...

at 03:35
The Japan Prize Foundation (President: Hiroshi Komiyama) held an award ceremony on Tuesday, April 16 at the Imperial Hotel Tokyo in Tokyo's Chiyoda Ward to confer the Japan Prize on scientists who have made creative and dramatic achievements in the...

at 03:30
AMSilk GmbH ("AMSilk"), a global leader in advanced materials made from spider silk-based proteins, today announces the appointments of Ralph Fraundorfer and Ctibor Kohutovic to its Management Board starting immediately. Ralph Fraundorfer has been...

at 02:54
HanxBio today announced that it has published a research article titled "Narazaciclib, a novel multikinase inhibitor with potent activity against CSF1R, FLT3 and CDK6, shows strong anti-AML activity in defined preclinical models" in the Nature...

at 02:50
International medical imaging IT and cybersecurity company Sectra (STO: SECT B) has signed two contracts to provide the radiology module of its enterprise imaging solution with two university medical centers in Germany?Universitätsklinikum Tübingen...



News published on and distributed by: